| First Author | Gao L | Year | 2013 |
| Journal | J Immunol | Volume | 190 |
| Issue | 2 | Pages | 689-94 |
| PubMed ID | 23241890 | Mgi Jnum | J:191724 |
| Mgi Id | MGI:5462480 | Doi | 10.4049/jimmunol.1103688 |
| Citation | Gao L, et al. (2013) Resolvin E1 and Chemokine-like Receptor 1 Mediate Bone Preservation. J Immunol 190(2):689-94 |
| abstractText | The polyunsaturated omega-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) enhances resolution of inflammation, prevents bone loss, and induces bone regeneration. Although the inflammation-resolving actions of RvE1 are characterized, the molecular mechanism of its bone-protective actions are of interest. To test the hypothesis that receptor-mediated events impact bone changes, we prepared transgenic mice overexpressing the RvE1 receptor chemokine-like receptor 1 (chemR23) on leukocytes. In zymosan-initiated peritonitis, neutrophil polymorphonuclear leukocyte infiltration in response to RvE1 was limited requiring log order lower doses in chemR23tg mice. Ligature-induced alveolar bone loss was diminished in chemR23tg mice. Local RvE1 treatment of uniform craniotomy in the parietal bone significantly accelerated regeneration of the bone defect. In in vitro bone cultures, RvE1 significantly enhanced expression of osteoprotegerin (OPG) without inducing change in receptor activator of NF-kappaB ligand levels, whereas the osteogenic markers alkaline phosphatase, bone sialoprotein, and Runt-related transcription factor 2 remained unchanged. These results indicate that RvE1 modulates osteoclast differentiation and bone remodeling by direct actions on bone, rescuing OPG production and restoring a favorable receptor activator of NF-kappaB ligand/OPG ratio, in addition to known anti-inflammatory and proresolving actions. |
